Cargando…
Development of genetic quality tests for good manufacturing practice-compliant induced pluripotent stem cells and their derivatives
Although human induced pluripotent stem cell (hiPSC) lines are karyotypically normal, they retain the potential for mutation in the genome. Accordingly, intensive and relevant quality controls for clinical-grade hiPSCs remain imperative. As a conceptual approach, we performed RNA-seq-based broad-ran...
Autores principales: | Jo, Hye-Yeong, Han, Hyo-Won, Jung, Inuk, Ju, Ji Hyeon, Park, Soon-Jung, Moon, Sunghwan, Geum, Dongho, Kim, Hyemin, Park, Han-Jin, Kim, Sun, Stacey, Glyn N., Koo, Soo Kyung, Park, Mi-Hyun, Kim, Jung-Hyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7054319/ https://www.ncbi.nlm.nih.gov/pubmed/32127560 http://dx.doi.org/10.1038/s41598-020-60466-9 |
Ejemplares similares
-
Perspectives on the cost of goods for hPSC banks for manufacture of cell therapies
por: Kim, Jung-Hyun, et al.
Publicado: (2022) -
Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell‐Derived Hepatocytes for Cell‐Based Therapy
por: Blackford, Samuel J.I., et al.
Publicado: (2018) -
Quality Control of Pharmacopuncture: A Comparative Study of Good Manufacturing Practice and External Herbal Dispensary Standards
por: Han, Ji-Eun, et al.
Publicado: (2021) -
Single-Cell RNA Sequencing of Human Pluripotent Stem Cell-Derived Macrophages for Quality Control of The Cell Therapy Product
por: Jo, Hye-Yeong, et al.
Publicado: (2022) -
Oriental medicine as collaborating treatments with conventional treatments for knee osteoarthritis: A PRISMA-compliant systematic review and meta-analysis
por: Park, Yeon-Cheol, et al.
Publicado: (2023)